CIK 0001719406
- Non-accelerated filer
- Smaller reporting company
NRX Pharmaceuticals, Inc.
Sign in to watch- Ticker
- NRXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822844431
- Phone
- +1 484-254-6134
- Business address
- 1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
- Former names
- Big Rock Partners Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-09 | Hurvitz Chaim Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-08-30 | Hurvitz Chaim Director | Purchase | +70,000 | $0.29 | $20K | 570,000 |
| 2022-11-18 | Hurvitz Chaim Director | Purchase | +40,408 | $1.10 | $44K | 500,000 |
| 2022-11-18 | Hurvitz Chaim Director | Purchase | +40,408 | $1.10 | $44K | 500,000 |
| 2022-11-17 | Hurvitz Chaim Director | Purchase | +171,780 | $1.08 | $186K | 459,592 |
| 2022-11-17 | Hurvitz Chaim Director | Purchase | +171,780 | $1.08 | $186K | 459,592 |
| 2022-11-16 | Hurvitz Chaim Director | Purchase | +287,812 | $0.99 | $285K | 287,812 |
| 2022-11-16 | Hurvitz Chaim Director | Purchase | +287,812 | $0.99 | $285K | 287,812 |
| 2022-10-21 | Hurvitz Chaim Director | Grant or award · Employee Stock Option | +162,660 | 381,083 | ||
| 2021-05-24 | Hurvitz Chaim Director | Grant or award | +1,436,350 | 1,436,350 | ||
| 2021-05-24 | Hurvitz Chaim Director | Grant or award | +208,443 | 208,443 | ||
| 2021-05-24 | Hurvitz Chaim Director | Grant or award · Common Stock Warrant (Right to buy) | +218,423 | 218,423 |
Page 1 of 1 · 12 trades